Skip to content
ppharmaranks
Menu

Alvimopan: uses, dosing, side effects & brands

Alvimopan is a medicine sold in the U.S. under one brand. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.

By the pharmaranks editorial teamReviewed against the FDA (openFDA label, NDC Directory & Enforcement) sourcesUpdated Jul 24, 2026How we research

Key facts

Available as
Capsule
Sold as
Entereg
Prescription?
Prescription only
Generic available?
Not in our catalog

Every alvimopan product we track (1)

Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.

Only one: Entereg.

What alvimopan pills look like

Imprint codes, colour and shape from the FDA’s labelling data. Match the imprint on your pill — or search any imprint.

Alvimopan pill imprints
ImprintStrengthColourShape
PAR301212 mgbluecapsule
54;8812 mgbluecapsule
54;8812 mgbluecapsule
231212 mgwhitecapsule

How long alvimopan keeps

No alvimopan label we read sets a separate limit for after opening, but they do specify how it must be stored — and the stability behind any date assumes those conditions.

Does alvimopan expire? The in-use limits and storage rules from its labels

What people report to the FDA about alvimopan

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 52 reports naming alvimopan, and the FDA flagged 96% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

  • hospitalisation19 reports
  • acute kidney injury5 reports
  • acute myocardial infarction5 reports
  • ileus3 reports
  • pruritus3 reports
  • urinary retention3 reports
  • adenocarcinoma of colon2 reports
  • cardio-respiratory arrest2 reports

Read these as a signal, not a rate. A report does not mean alvimopan caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label section above.

Source: openFDA drug/event (FAERS), retrieved July 25, 2026.

Related calculators

Frequently asked questions

Can you take alvimopan with other medicines?

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run alvimopan against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

What forms does alvimopan come in?

Across the brands we track, alvimopan is currently marketed as capsule, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Is there a generic alvimopan?

We do not currently list a generic-labelled alvimopan product. That does not always mean none exists — it means none appears under a generic name in the FDA data we track. Ask your pharmacist.

Cite this page
APA
pharmaranks. (2026, July 24). Alvimopan: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/alvimopan
MLA
“Alvimopan: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/alvimopan.

We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.

Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.

Read the full FDA label for alvimopan on DailyMed (NIH) ↗.